2014-05-27 Just look, but don’t touch: EMA terms of use for clinical study data are impracticable Data are only allowed to be viewed on screen / Pre-censorship by drug manufacturers The European Medicines Agency (EMA) receives comprehensive clinical study data… Read More ›
European Medicines Agency
Europe says No to drug data access ” arguing that this would undermine commercial interests and that there was no overriding public interest in disclosure”
Public release date: 10-May-2011 – Request Repost Drug regulators are protecting profits over patients, warn researchers Analysis: Opening up data at the European Medicines Agency Medicines regulators are protecting drug company profits rather than the lives and welfare of patients… Read More ›
Current study shows: Important information on effects and side effects of drugs is missing in most publications
IQWiG: Reliable assessment of drugs is only possible on the basis of clinical study reports (CSRs) In 2012 researchers from the German Institute for Quality and Efficiency in Health Care (IQWiG) presented a study in the BMJ analysing information sources… Read More ›
Investigation into safety of new diabetes drugs — will manufacturers release their data?
Contact: Emma Dickinson edickinson@bmj.com 44-207-383-6529 BMJ-British Medical Journal Joint BMJ/Channel 4 Dispatches investigation The BMJ and Channel 4 Dispatches investigated and found that evidence suggesting potential harm from the drugs in industry studies has not been published. Some independent studies… Read More ›
Release all Tamiflu data as promised, argue researchers
Contact: Emma Dickinson edickinson@bmjgroup.com 44-020-738-36529 BMJ-British Medical Journal Company plans to set up review board, but researchers want it to keep its promise The latest correspondence is posted online today as part of the BMJ‘s open data campaign, aimed at… Read More ›
BMJ editor urges Roche to fulfil promise to release Tamiflu trial data: Or anything that shows the drug does more good than harm.
Contact: Stephanie Burns sburns@bmjgroup.com 44-020-738-36920 BMJ-British Medical Journal BMJ editor urges Roche to fulfil promise to release Tamiflu trial data Journal launches open data campaign to compel greater accountability in healthcare In an open letter to company director, Professor Sir… Read More ›
France, Germany, Spain, Italy, and Switzerland now imposing partial ban on the Novartis Flu Vaccine
France halts sale of Novartis flu vaccine Fri, 26 Oct 2012 14:18 GMT Source: reuters (Adds comment from European Medicines Agency) PARIS, Oct 26 (Reuters) – France said it was halting sales of an influenza vaccine made by Swiss drugmaker… Read More ›
Effects of Tamiflu still uncertain, warn experts, as Roche continues to withhold key trial data
2 years after pharmaceutical giant Roche promised the BMJ it would release key Tamiflu trial data for independent scrutiny, the safety and effectiveness of this anti-influenza drug remains uncertain, warn experts today Two years after pharmaceutical giant Roche promised the… Read More ›
Roche under investigation by UK watchdogs
Drug giant probed for not disclosing 15,000 patient death reports: Roche under investigation by UK watchdogs after 80,000 ‘adverse reactions‘ By Jo Macfarlane PUBLISHED:16:48 EST, 7 July 2012 | UPDATED:08:20 EST, 8 July 2012 One of the world’s biggest drug… Read More ›
